Terms of the acquisition were not disclosed.
ProteOptics' technology involves the use of image analysis to track optical changes without the need of any molecular labeling in order to monitor biomolecular interactions, and is expected to expand Bio-Rad's proteomics' product offerings, Bio-Rad said.